- Home
- GGAL vs MASI Comparison
GGAL vs MASI Comparison
Compare GGAL & MASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GGAL | MASI |
|---|---|---|
| Founded | 1905 | 1989 |
| Country | Argentina | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.4B | 9.2B |
| IPO Year | N/A | 2000 |
Fundamental Metrics
Financial Performance| Metric | GGAL | MASI |
|---|---|---|
| Price | $42.06 | $176.03 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 6 |
| Target Price | $69.00 | ★ $184.25 |
| AVG Volume (30 Days) | 1.2M | ★ 2.6M |
| Earning Date | 01-01-0001 | 03-30-2026 |
| Dividend Yield | ★ 3.42% | N/A |
| EPS Growth | N/A | ★ 51.05 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,239,153,000.00 |
| Revenue This Year | $50.70 | $8.59 |
| Revenue Next Year | N/A | $7.60 |
| P/E Ratio | $13.36 | ★ N/A |
| Revenue Growth | N/A | ★ 8.34 |
| 52 Week Low | $25.89 | $125.94 |
| 52 Week High | $66.24 | $176.19 |
Technical Indicators
Market Signals| Indicator | GGAL | MASI |
|---|---|---|
| Relative Strength Index (RSI) | 39.62 | 75.92 |
| Support Level | $25.97 | $157.54 |
| Resistance Level | $45.86 | N/A |
| Average True Range (ATR) | 2.01 | 0.34 |
| MACD | -0.05 | -1.24 |
| Stochastic Oscillator | 26.16 | 69.77 |
Price Performance
Historical ComparisonAbout GGAL Grupo Financiero Galicia S.A.
Grupo Financiero Galicia SA is a financial service holding company. It provides general banking services, proprietary brand credit card services, personal loans, insurance, and other services. The company's operating business segments are Banks, Ecosistema Naranja X, Insurance, Adjustments, and Other Businesses. It generates maximum revenue from Banks. Geographically its operate in Argentina, Uruguay, and the majority of its revenue comes from Argentina.
About MASI Masimo Corporation
Masimo Corp is a medical technology company. The company oepates in single segment namely Healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. The company sells its products to hospitals, emergency medical service providers, home care providers, physician offices, veterinarians, and others.